What Is A Clinical Trial Protocol
All clinical trials follow a carefully designed plan called a protocol. This protocol acts as a set of rules and guidelines to ensure the study is conducted safely, consistently, and scientifically. It helps researchers measure the right outcomes in the right way and ensures that results are reliable and meaningful.
A Protocol Includes:
Who Can Participate
Clear criteria outlining who is eligible to join the trial (based on age, condition, medical history, etc.).
Study Procedures
The specific tests, assessments, and research methods to be used throughout the study.
Treatment Details
Information about the intervention (such as a drug, device, or procedure), including how and when it will be given.
Study Timeline & Data Collection
How long the trial will run, what data will be collected, and whether any follow-up will occur after the trial ends.
At Ophthalmic Trials Australia, every study we run strictly follows a protocol that has been reviewed and approved by an independent ethics committee (HREC) and our internal governance officer, helping protect the rights, safety, and well-being of all participants. It is commonplace to receive a proposal from a sponsor or clinical research organisation and decline to be involved due to our stringent screening procedures even before a HREC application is started.
What Is a Control Group?
In many clinical trials, participants are divided into different groups to help researchers compare the effects of a new treatment. One of these is called the control group.
Purpose of a Control Group
A control group helps researchers understand whether the treatment being studied works by comparing it to either:
A placebo (an inactive substance with no therapeutic effect – often the vehicle for the investigational product), or
The current standard treatment which has already been approved for use.
This comparison allows scientists to measure the difference in outcomes between those receiving the new intervention and those who are not.
How It Works
Participants are usually randomly assigned to either the treatment group or the control group. This process is called randomisation and ensures that the results are fair and unbiased.
In many studies, the trial is also masked (sometimes this term is “blinded,” which should not be used in ophthalmic clinical trials), meaning:
- You may not know which group you are in (single-masked), and
- In some cases, even the research staff may not know (double-masked) until the study ends. Although there is an independent team on the study that is unmasked.
Why Control Groups Matter
Without a control group, it would be difficult to know whether a treatment truly works or if other factors—like natural recovery or psychological expectations—are responsible for the changes seen. Some study designs have a crossover design, which means that both groups in the study are on the active investigational product for a period of time.
Control groups are essential for producing trustworthy, scientifically valid results. At Ophthalmic Trials Australia, we design and conduct trials that meet the highest standards of clinical research to help improve treatments for eye diseases.
Comparing a new intervention with a standard Treatment
In many clinical trials, researchers compare a new intervention—such as a medication, device, or procedure—with an existing standard treatment to determine which is more effective or safer.
Why Compare Treatments?
The goal is to find out whether the new approach:
- Works better than current treatments
- Has fewer side effects and better tolerability
- Improves quality of life
- Offers other advantages, such as easier use or longer-lasting results, less dosing, etc.
By comparing the new treatment with what is already available, researchers ensure that only improvements are adopted into standard medical practice.
How the Comparison Works
Participants are randomly assigned to either:
- The new intervention group, or
- The standard treatment group
This randomisation helps ensure the results are fair, unbiased, and scientifically valid.
In some cases, trials may also include a placebo group if there is no established standard treatment, but where one exists, it is considered best practice to compare new treatments directly against the current standard of care.
What It Means for You
If you join a trial comparing two treatments:
- You will receive either the new treatment or the standard one, never less than the current best available care
- Your safety and progress will be monitored closely throughout the study
- You are helping determine whether future patients could benefit from more effective therapies
At Ophthalmic Trials Australia, our mission is to support the development of new eye treatments through thorough, ethical, and scientifically sound research. We work closely with patients, doctors, and researchers to ensure that every treatment we test is evaluated with care, integrity, and a focus on real-world impact. Our goal is to help bring safe and effective solutions to those living with eye conditions—solutions that truly improve quality of life. By participating in and supporting clinical trials, we’re helping shape the future of eye care and giving patients access to innovative therapies that can protect and restore their sight.
Comparing a new intervention with a placebo
In some clinical trials, researchers compare a new treatment with a placebo to understand how well the new treatment works. In the 90’s this was called the “Pepsi Challenge”. Pepsi could be compared to Coca-Cola taste-wise, and vice versa.
What Is a Placebo?
A placebo is a substance or treatment that looks like the real intervention but has no active therapeutic effect. It is designed to mimic the real treatment in appearance and method of administration (e.g., eye drops, tablets, or injections), but it does not contain the active ingredient. If we are testing an experimental device, procedure, or intervention, it may be referred to as the “sham”.
Why Use a Placebo
Comparing a new treatment to a placebo helps researchers:
- Determine if the treatment’s effects are real or due to chance or expectation
- Identify any side effects caused specifically by the treatment
- Measure improvements in symptoms more accurately
- Measure the effect of the vehicle (alone) for the investigational product
This method helps ensure that the benefits seen are truly due to the new intervention, and not just a placebo effect(feeling better simply because you believe you’re being treated).
How It Works
Participants are randomly assigned to receive either:
- The new treatment, or
- The placebo
In most cases, neither the participant nor the study staff knows who is receiving which—this is called a double-masked study and helps ensure results are unbiased and scientifically valid.
Is It Ethical?
Placebo-controlled trials are only used when:
- There is no existing standard treatment, or
- The new treatment is being tested in addition to standard care
All placebo use in Australia is carefully reviewed and approved by independent ethics committees to ensure participants are never denied appropriate medical care. HREC and Internal Governance have cleared the use of the placebo in the trial.
At Ophthalmic Trials Australia, we place the highest importance on participant safety, clear communication, and ethical conduct. Every person who joins a trial is fully informed and voluntarily consents about what to expect, including whether a placebo is involved. Participation is completely voluntary, and individuals are free to withdraw at any time. We take the time to answer questions, explain the process clearly, and ensure that everyone feels confident and respected throughout their involvement. Our commitment is to conduct research with honesty and care, always putting the well-being and rights of our participants first in the journey toward better eye treatments.
What Is the Placebo Effect?
The placebo effect is a real psychological and physiological response that can occur when a person experiences an improvement in symptoms, even though they’ve received a treatment with no active medical ingredient (called a placebo).
How Does It Happen?
When people believe they are receiving an effective treatment, their body and brain can respond as if they are on the active investigational product. This belief can lead to measurable subjective improvements in how they feel, such as:
- Reduced pain or discomfort
- Improved mood or sleep
- A general sense of well-being
This doesn’t mean the symptoms are imagined; rather, it highlights the powerful connection between the mind and body. Our investigators collect both the subjective responses from the participants and the objective measurements from the clinical testing. Sometimes these two findings disagree, and this may be due to the placebo effect.
Why is the Placebo Effect Important in Clinical Trials?
In research, the placebo effect must be taken into account to determine whether a new treatment is truly effective.
That’s why many trials use a placebo group. By comparing participants who receive the real treatment with those who receive the placebo, researchers can clearly see whether improvements are due to the treatment itself—or simply the expectation of getting better.
What You Should Know as a Participant
- If you take part in a trial, you might be assigned to a placebo group depending on the study design.
- You will always be informed if a placebo is involved.
- You’ll still receive close monitoring and care, and in many cases, placebo-controlled trials are short-term or followed by an open-label phase, where all participants may receive the real treatment.
At Ophthalmic Trials Australia, all trials involving placebos are carefully designed and ethically reviewed to ensure participant safety, clarity, and transparency at every step.
How Many People Take Part in a Clinical Trial?
The number of participants in a clinical trial depends on the trial’s goals, phase, and design. Some studies involve just a few people, while others may include thousands across multiple sites or countries.
Typical Numbers by Trial Phase:
- Phase 1 (Safety Testing):
Involves a small group of 20 to 100 volunteers or patients. The goal is to assess safety, dosage, and how the treatment behaves in the body. - Phase 2 (Effectiveness and Side Effects):
Includes around 100 to 300 participants who have the condition being studied. This phase helps determine how well the treatment works and monitors for side effects. - Phase 3 (Large-Scale Comparison):
Involves several hundred to several thousand participants. It compares the new treatment to standard therapies or a placebo and collects more safety data. - Phase 4 (Post-Marketing Surveillance):
Conducted after a treatment is approved, this phase can include thousands of people to monitor long-term effects and performance in real-world settings.
At Ophthalmic Trials Australia, our studies range from small-scale early-phase trials to large, multi-centre Phase 3 and 4 studies. Every participant plays a critical role in helping improve treatments for eye conditions.
What Is Randomisation?
Randomisation is a key part of clinical trial design that ensures the study results are fair, unbiased, and scientifically valid.
What Does It Mean?
In a randomised trial, participants are assigned by chance (not by choice or decision of the doctors or researchers) to one of two or more groups. These groups might include:
- A treatment group receiving the new intervention
- A control group receiving a placebo or standard treatment
This process is similar to flipping a coin or using a computer-generated list to assign participants.
What You Should Know as a Participant
- You won’t choose which group you are in, and neither will the research team.
- In many trials, neither you nor the researchers will know which treatment you’re receiving—this is called a double-masked study.
- Randomisation is done to protect the integrity of the study and ensure that results can be trusted by doctors, regulators, and the wider scientific community.
Why Is Randomisation Important?
Randomisation helps to:
- Ensure each group is similar in age, gender, health status, and other factors
- Eliminate bias, where certain types of participants might otherwise be more likely to receive a specific treatment
- Make sure any differences in outcomes are due to the treatment being tested, not other variables
At Ophthalmic Trials Australia, all of our trials use ethically approved randomisation methods to ensure the highest standards of scientific accuracy and participant safety.
What Is Masking/Blinding in a Clinical Trial?
Blinding, or the preferred term in ophthalmic clinical trials, is masking, is a technique used in clinical trials to help ensure the results are objective, unbiased, and scientifically valid.
What Does Masking Mean?
Masking means that certain people involved in the study do not know which treatment a participant is receiving: the active treatment, placebo, or standard care. This prevents expectations or assumptions from influencing the results.
Types of Masking:
- Single-Mask Trial
Only the participant does not know which group they are in. The research team does. - Double-Mask Trial
Both the participant and the research team are unaware of the treatment assignment. This is the most common and reliable type of blinding. - Triple-Mask Trial
In some studies, even the people analysing the data don’t know who received which treatment until the study is complete.
- treatment until the study is complete.
Why Is Masking Important?
Masking helps to:
- Prevent bias in how symptoms are reported or interpreted
- Ensure that treatment results are based on real effects, not expectations
- Protect the scientific integrity of the study
When Is Masking Used?
Masking is commonly used in trials comparing a new treatment to a placebo or standard treatment. However, not all trials can be masked: for example, when comparing surgical procedures or physical therapies, where its clear which intervention was received.
At Ophthalmic Trials Australia, we follow strict, ethics-approved protocols to ensure proper masking wherever possible. This safeguards both the quality of our data and the experience of our participants. Our masked and unmasked teams are very experienced, and the safety of each participant, along with the anonymity, are our priority.